Table of Contents Author Guidelines Submit a Manuscript
International Journal of Analytical Chemistry
Volume 2017, Article ID 1389807, 6 pages
https://doi.org/10.1155/2017/1389807
Research Article

Simple Quantification of Pentosidine in Human Urine and Plasma by High-Performance Liquid Chromatography

1College of Pharmacy and Research, Institute of Pharmaceutical Science and Technology, Ajou University, Suwon 16499, Republic of Korea
2Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Republic of Korea

Correspondence should be addressed to So Hee Kim; rk.ca.uoja@76mikhs

Received 13 June 2017; Accepted 13 September 2017; Published 18 October 2017

Academic Editor: Mohamed Abdel-Rehim

Copyright © 2017 Ji Sang Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Miyata, Y. Ueda, K. Horie et al., “Renal catabolism of advanced glycation end products: The fate of pentosidine,” Kidney International, vol. 53, no. 2, pp. 416–422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. J. R. Chen, M. Takahashi, M. Suzuki, K. Kushida, S. Miyamoto, and T. Inoue, “Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis,” Rheumatology, vol. 38, no. 12, pp. 1275–1278, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. D. R. Sell, A. Lapolla, P. Odetti, J. Fogarty, and V. M. Monnier, “Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM,” Diabetes, vol. 41, no. 10, pp. 1286–1292, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. D. R. Sell and V. M. Monnier, “End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen,” The Journal of Clinical Investigation, vol. 85, no. 2, pp. 380–384, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Odetti, J. Fogarty, D. R. Sell, and V. M. Monnier, “Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects,” Diabetes, vol. 41, no. 2, pp. 153–159, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. R. C. Chaney Jr., K. P. Blemings, J. Bonner, and H. Klandorf, “Pentosidine as a measure of chronological age in wild birds,” The Auk, vol. 120, no. 2, pp. 394–399, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Shiraki, T. Kuroda, Y. Shiraki, S. Tanaka, T. Higuchi, and M. Saito, “Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment,” Journal of Bone and Mineral Metabolism, vol. 29, no. 1, pp. 62–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Takahashi, M. Suzuki, K. Kushida, S. Miyamoto, and T. Inoue, “Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis,” Rheumatology, vol. 36, no. 6, pp. 637–642, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Yoshihara, K. Nakamura, M. Kanai et al., “Determination of urinary and serum pentosidine and its application to elder patients,” Biological & Pharmaceutical Bulletin, vol. 21, no. 10, pp. 1005–1008, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Takahashi, H. Hoshino, K. Kushida, K. Kawana, and T. Inoue, “Direct quantification of pentosidine in urine and serum by HPLC with column switching,” Clinical Chemistry, vol. 42, no. 9, pp. 1439–1444, 1996. View at Google Scholar · View at Scopus
  11. S. Taneda and V. M. Monnier, “ELISA of pentosidine, an advanced glycation end product, in biological specimens,” Clinical Chemistry, vol. 40, no. 9, pp. 1766–1773, 1994. View at Google Scholar · View at Scopus
  12. E. S. Du, H. S. Moon, S.-J. Lim, S. Y. Chang, and S. H. Kim, “High performance liquid chromatographic determination of YJC-10592, a new chemokine receptor 2 (CCR-2) antagonist, in biological samples,” Journal of Pharmaceutical Investigation, vol. 46, no. 5, pp. 495–504, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Westermann, W. Hubl, N. Kaiser, and L. Salewski, “Simple, rapid and sensitive determination of epinephrine and norepinephrine in urine and plasma by non-competitive enzyme immunoassay, compared with HPLC method,” Clinical Laboratory, vol. 48, no. 1-2, pp. 61–72, 2002. View at Google Scholar · View at Scopus
  14. S. Nag, J.-J. Qin, S. Voruganti et al., “Development and validation of a rapid HPLC method for quantitation of SP-141, a novel pyrido[b]indole anticancer agent, and an initial pharmacokinetic study in mice,” Biomedical Chromatography, vol. 29, no. 5, pp. 654–663, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. D. G. Dyer, J. A. Blackledge, S. R. Thorpet, and J. W. Baynes, “Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo,” The Journal of Biological Chemistry, vol. 266, no. 18, pp. 11654–11660, 1991. View at Google Scholar · View at Scopus
  16. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, and Center for Veterinary Medicine, Guidance for Industry, Bioanalytical Method Validation, 2013.
  17. A. S. Sim, C. Salonikas, D. Naidoo, and D. E. L. Wilcken, “Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard,” Journal of Chromatography B, vol. 785, no. 2, pp. 337–344, 2003. View at Publisher · View at Google Scholar · View at Scopus